|
|
Volumn 23, Issue 7, 2009, Pages 869-
|
|
Maraviroc and CD4+ cell count recovery in patients with virologic suppression and blunted CD4 cell response
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
MARAVIROC;
VIRUS RNA;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
CYCLOHEXANE DERIVATIVE;
TRIAZOLE DERIVATIVE;
ADD ON THERAPY;
ALLELE;
CD4 LYMPHOCYTE COUNT;
CD4+ T LYMPHOCYTE;
CELL MIGRATION;
CELLULAR IMMUNITY;
CLINICAL TRIAL;
CONVALESCENCE;
DRUG EFFECT;
FOLLOW UP;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION;
HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT;
LETTER;
LYMPHOCYTE ACTIVATION;
MENINGOENCEPHALITIS;
NONHUMAN;
PREVALENCE;
PRIORITY JOURNAL;
TICK BORNE ENCEPHALITIS;
TREATMENT OUTCOME;
VIRUS INFECTION;
VIRUS INHIBITION;
WEST NILE FLAVIVIRUS;
DRUG INTERACTION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOLOGY;
METHODOLOGY;
NOTE;
VIRUS LOAD;
ANTI-HIV AGENTS;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
CD4 LYMPHOCYTE COUNT;
CYCLOHEXANES;
DRUG INTERACTIONS;
HIV INFECTIONS;
HIV-1;
HUMANS;
TRIAZOLES;
VIRAL LOAD;
|
|
EID: 67649664236
PISSN: 02699370
EISSN: 14735571
Source Type: Journal
DOI: 10.1097/QAD.0b013e3283262aa0 Document Type: Letter |
|
Times cited : (5)
|
|
References (5)
|
